Cleared Traditional

K130933 - SOLUTIS

K130933 is an FDA 510(k) clearance for SOLUTIS, manufactured by Quantel Medical. The device is a Class 2 Ophthalmic device with product code HQF cleared through the Traditional 510(k) pathway after a 120-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2013
Decision
120d
Days
Class 2
Risk

K130933 is an FDA 510(k) clearance for the SOLUTIS. Classified as Laser, Ophthalmic (product code HQF), Class II - Special Controls.

Submitted by Quantel Medical (North Reading, US). The FDA issued a Cleared decision on August 2, 2013 after a review of 120 days - within the typical 510(k) review window.

This device falls under the Ophthalmic FDA review panel, regulated under 21 CFR 886.4390 - the FDA ophthalmic device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Ophthalmic review framework, consistent with the majority of Class II 510(k) submissions.

View all Quantel Medical devices

FDA 510(k) Submission Details - K130933

510(k) Number K130933 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 04, 2013
Decision Date August 02, 2013
Days to Decision 120 days
Submission Type Traditional
Review Panel Ophthalmic (OP)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
10d slower than avg
Panel avg: 110d · This submission: 120d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

HQF Device Classification - Class 2, Special Controls

Product Code HQF Laser, Ophthalmic
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 886.4390
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Ophthalmic devices follow this clearance model.

Regulatory Peers - HQF Laser, Ophthalmic

All 137
Devices cleared under the same product code (HQF) and FDA review panel - the closest regulatory comparables to K130933.
SCANNING LASERLINK
K130195 · Lumenis, Inc. · Nov 2013
FEMTO LDV(TM) Z-GENERATION FEMTOSECOND SURGICAL LASER
K131207 · Surgical Instrument Engineering AG · Oct 2013
LIGHTLAS FAMILY OF MULTI-WAVELENGTH MEDICAL LASER SYSTEM
K124043 · Lightmed Corp. · Sep 2013
ELLEX 2RT
K122202 · Ellex Medical Pty, Ltd. · Jul 2013
PASCAL SYNTHESIS (532NM/577NM) OPTHALMIC LASER
K123542 · Topcon Medical Laser Systems, Inc. · May 2013
PASCAL LASER INDIRECT OPHTHALMOSCOPE
K123056 · Topcon Medical Laser Systems, Inc. (Tmls) · Nov 2012